Next announces results of Nexrutine dietary supplement study
SALINAS, Calif. Next Pharmaceuticals announced Thursday the results of a clinical study on Nexrutine, conducted at The LaValle Metabolic Institute in Cincinnati.
The study concluded that Nexrutine, when used as a dietary supplement, helps in the management of pain and/or inflammation and helps promote a restful sleep with minimal side effects.
“Suffering from pain and inflammation can be a life-changing challenge,” stated Jim LaValle, founder of The LaValle Metabolic Institute and author of many books, including Cracking the Metabolic Code and the Cox-2 Connection. “Many of our patients are relieved to find a natural remedy that is not only cardio protective, but unlike aspirin, is easy on the stomach. This study demonstrates that Nexrutine has an excellent safety profile.”
Out of the 401 participants in the study, 92 percent reported Nexrutine provided pain relief and 93 percent reported improvement in their overall condition.
Nexrutine is a proprietary blend of natural ingredients developed to address general aches and pains associated with physical activity and over-exertion.
The clinical trial was designed to be an open label, single center, clinical trial.
Signalife gets FDA approval to market cardio monitoring card
LOS ANGELES Signalife on Monday received Food and Drug Administration 510(k) clearance to market and sell without a prescription its ambulatory event recorder.
The device, which Signalife will market as the Fidelity 200 HeartLife Tempo Card, is a flexible, credit-card-sized heart monitoring device that can be used as an early-detection system by patients who desire to independently monitor their heart health.
The card will enable the patient to measure cardiovascular activity during exercise or other everyday activities by holding the event recorder to his/her chest, pressing the “record” button, and recording up to a 45-second event.
The recordings may increase the ability to detect silent ischemia or other difficult to detect abnormalities of the heart.
The event recorder will be capable of storing up to six, 45-second recordings. The patient will then either take the recorder to his or her physician for review, or transmit the data to a subscription-based 24-hour monitoring center where it can be immediately evaluated by a qualified ECG technician, cardiac nurse or cardiologist.
The company anticipates that a final production model of the Fidelity 200 HeartLife Tempo Card will be introduced into the market in the first quarter of 2008.
CDC study finds obesity rates leveling off in 2005-06
ATLANTA After a quarter century of increases, obesity prevalence has not measurably increased in the past few years though levels are still high—at 34 percent of U.S. adults aged 20 and over, according to a new study released Wednesday by the Centers for Disease Control and Prevention.
“Since 1999, there appears to have been a leveling off in obesity among women, but the trend is less clear among men,” stated Cynthia Ogden, a CDC researcher and lead author of the study. “We do know however that the gap between men and women has narrowed in recent years, with men catching up to the higher rates among women.”
The study found:
- More than 72 million U.S. citizens were obese (body-mass index of greater than 30) in 2005-2006. This includes 33.3 percent of men and 35.3 percent of women. The figures show no statistically significant change from 2003-04, when 31.1 percent of men were obese and 33.2 percent of women were obese;
- Adults aged 40 to 59 had the highest obesity prevalence compared with other age groups. Approximately 40 percent of men in this age group were obese, compared with 28 percent of men aged 20-39, and 32 percent of men aged 60 and older. Among women, 41 percent of those aged 40-59 were obese compared with 30.5 percent of women aged 20-39. Women aged 65 and older had obesity prevalence rates comparable to women in the 20 to 39 age group;
- There were large race-ethnic disparities in obesity prevalence among women. Approximately 53 percent of non-Hispanic black women and 51 percent of Mexican-American women aged 40-59 were obese compared to about 39 percent of non-Hispanic white women of the same age. Among women 60 and older, 61 percent of non-Hispanic black women were obese compared to 37 percent of Mexican-American women and 32 percent of non-Hispanic white women.
The report, “Obesity Among Adults in the U.S.: No Significant Change in 2005-06,” is the latest analysis based on the National Health and Nutrition Examination Survey, conducted by CDC?s National Center for Health Statistics. The full report is available at www.cdc.gov/nchs.